When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APRE - Aprea's eprenetapopt Fast Track'd for type of blood cancer
Aprea Therapeutics Inc.
The FDA grants Fast Track status to Aprea Therapeutics' (APRE) eprenetapopt for the treatment of acute myeloid leukemia ((AML)).Fast Track provides for more frequent interaction with the FDA review team and a rolling review of the marketing application.Small molecule eprenetapopt reactivates a tumor suppressor protein called p53 thereby inducing programmed cell death in cancer cells.Shares up 2% premarket on light volume.